Correlation Between BriaCell Therapeutics and Dermata Therapeutics
Can any of the company-specific risk be diversified away by investing in both BriaCell Therapeutics and Dermata Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BriaCell Therapeutics and Dermata Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BriaCell Therapeutics Corp and Dermata Therapeutics Warrant, you can compare the effects of market volatilities on BriaCell Therapeutics and Dermata Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BriaCell Therapeutics with a short position of Dermata Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of BriaCell Therapeutics and Dermata Therapeutics.
Diversification Opportunities for BriaCell Therapeutics and Dermata Therapeutics
0.13 | Correlation Coefficient |
Average diversification
The 3 months correlation between BriaCell and Dermata is 0.13. Overlapping area represents the amount of risk that can be diversified away by holding BriaCell Therapeutics Corp and Dermata Therapeutics Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dermata Therapeutics and BriaCell Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BriaCell Therapeutics Corp are associated (or correlated) with Dermata Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dermata Therapeutics has no effect on the direction of BriaCell Therapeutics i.e., BriaCell Therapeutics and Dermata Therapeutics go up and down completely randomly.
Pair Corralation between BriaCell Therapeutics and Dermata Therapeutics
Assuming the 90 days horizon BriaCell Therapeutics is expected to generate 211.7 times less return on investment than Dermata Therapeutics. But when comparing it to its historical volatility, BriaCell Therapeutics Corp is 27.45 times less risky than Dermata Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Dermata Therapeutics Warrant is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 0.81 in Dermata Therapeutics Warrant on September 1, 2024 and sell it today you would earn a total of 0.07 from holding Dermata Therapeutics Warrant or generate 8.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 42.4% |
| Values | Daily Returns |
BriaCell Therapeutics Corp vs. Dermata Therapeutics Warrant
Performance |
| Timeline |
| BriaCell Therapeutics |
| Dermata Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Solid
BriaCell Therapeutics and Dermata Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BriaCell Therapeutics and Dermata Therapeutics
The main advantage of trading using opposite BriaCell Therapeutics and Dermata Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BriaCell Therapeutics position performs unexpectedly, Dermata Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dermata Therapeutics will offset losses from the drop in Dermata Therapeutics' long position.| BriaCell Therapeutics vs. Tff Pharmaceuticals | BriaCell Therapeutics vs. Eliem Therapeutics | BriaCell Therapeutics vs. Inhibrx | BriaCell Therapeutics vs. Enliven Therapeutics |
| Dermata Therapeutics vs. Tff Pharmaceuticals | Dermata Therapeutics vs. Eliem Therapeutics | Dermata Therapeutics vs. Inhibrx | Dermata Therapeutics vs. Enliven Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Other Complementary Tools
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |